01/27/2023
6:20 AM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
7:13 AM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
7:16 AM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
7:19 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2023
7:21 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2023
7:38 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/08/2022
6:06 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2022
6:21 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2022
6:15 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2022
6:43 AM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2022
7:57 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2022
7:59 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2022
3:20 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2022
3:32 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2022
4:28 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2022
4:06 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2022
4:09 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2022
3:21 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2022
9:49 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2022
5:39 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2022
6:33 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2022
6:36 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:52 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:54 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:56 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:57 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
4:01 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2022
3:44 PM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:46 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:48 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:50 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:39 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2022
3:41 PM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2022
6:17 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2022
6:07 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2022
6:36 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2022
6:38 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2022
6:35 AM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2022
6:04 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2022
6:05 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/08/2022
6:05 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2022
6:09 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/25/2022
3:23 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2022
3:26 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2022
6:05 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2022
6:08 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/20/2022
3:34 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2022
6:18 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2022
6:16 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2021
6:23 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2021
3:02 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2021
5:14 PM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2021
4:29 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2021
5:56 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2021
6:09 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2021
8:46 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2021
7:09 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2021
7:56 AM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2021
8:50 AM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/01/2021
6:36 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2021
6:40 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/23/2021
7:50 AM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:52 AM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:53 AM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:54 AM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:58 AM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:41 AM | Immunovant (Issuer)
Jain Rita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:43 AM | Elliott Michael James (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:45 AM | Immunovant (Issuer)
Yanchik Connealy Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:46 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/23/2021
7:39 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
7:24 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/16/2021
7:24 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2021
5:52 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2021
3:39 PM | Immunovant (Issuer)
Jain Rita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2021
8:03 AM | Immunovant (Issuer)
Jain Rita (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/04/2021
7:33 AM | Immunovant (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/12/2020
7:28 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2020
7:30 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/18/2020
3:33 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
3:13 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2020
4:09 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2020
4:29 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2020
4:03 PM | Elliott Michael James (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2020
5:16 AM | Immunovant (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/25/2020
8:07 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2020
7:22 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2020
3:18 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2020
7:30 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/29/2020
7:21 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/18/2020
7:47 AM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:52 AM | Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:31 AM | Immunovant (Issuer)
Yanchik Connealy Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:37 AM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:40 AM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:42 AM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:22 AM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:26 AM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:28 AM | Immunovant (Issuer)
MIDDLEKAUFF W BRADFORD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
6:25 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
